- RA, Forbion and Sanofi Ventures appear to back new eye drug from KoreaThe trend continues in which big-name venture investors band together to back new companies with an experimental medicine developed by another biotech. RA Capital and Forbion — partners on a coup…Endpoints · 1mo ago↗ source
- Novocure’s electric fields therapy fails key glioblastoma studyNovocure reported Thursday morning that its electric fields device combined with chemoradiation failed to extend glioblastoma patients' lives in a Phase 3 study, dampening the company's hopes of ex…Endpoints · 1mo ago↗ source
- Innoviva revives Lyndra's long-acting oral drug platformA healthcare asset and royalties holding company is bringing a long-acting oral medicine approach back to life, resurrecting a drug delivery platform that had accumulated more than $380 million in…